Zim Laboratories Limited
Incorporated in 1989, Zim LaboratoriesLtd manufactures formulation drugs andpre formulation ingredients in India andmarkets and sells these within and outside India
What Zim files
- Others74
- Investor Meet33
- Important19
- Board Meeting13
- Updates9
- JV/Acquisition6
ZIMLAB allotted 1,09,451 equity shares to employees via ESOP 2023 at Rs. 77.40 each, raising Rs. 0.847 Cr. Total shares now stand at 5.36 crore. This event slightly dilutes existing shareholders.
ZIM Labs allotted 47.64 lakh Equity Shares via preferential issue to Florintree Trinex LLP (non-promoter) at ₹73.46/share, raising ~₹35 Cr. This investor now holds 8.91%, and the company's paid-up capital rises from ₹48.74 Cr to ₹53.50 Cr.
Zim Labs will issue up to 47.64 lakh equity shares at ₹73.46 per share via a preferential issue to Florintree Trinex LLP, aiming to raise approx. ₹35 Cr. Shareholder approval for this private placement is scheduled for February 16, 2026.